Andrew Tepperman

Vice President
Andrew Tepperman | Life Sciences Litigation | Charles River Associates

Andrew Tepperman is a vice president in CRA’s Life Sciences Practice.  Dr. Tepperman has deep experience conducting economic analyses in legal matters involving intellectual property, antitrust, and other commercial disputes, including international arbitrations.

Within the life sciences sector, he has had many engagements involving damages assessment for patent and trade secret infringement, ANDA litigation, patent settlement agreements, monopolization, and breach of contract claims.  He has provided expert testimony in Canadian and U.S. court proceedings.

Before joining CRA in 2001, Dr. Tepperman lectured at the University of Toronto and conducted research funded by Industry Canada on the international determinants of patenting. His doctoral dissertation, entitled “The Implications of Intellectual Property Rights for Firm Strategy and Organizational Choice,” was completed in 2001.

Selected Engagements

  • 01
    CRA addressed a claim that a company had improperly failed to pay required development milestones upon termination of a drug development program
    In litigation before the Delaware Court of Chancery, a CRA expert was asked to address the basis for a company’s decision to terminate the development of a...
    View engagement
  • 02
    ANDA challenge - Shire, Sanofi-Aventis, and Firazyr
    Shire, Sanofi-Aventis and Firazyr CRA consultants advised counsel to Shire Orphan Therapies, LLC (Shire) and Sanofi-Aventis Deutschland GMBH (Sanofi-Aventis)...
    View engagement
  • 03
    Endo and Opana ER ANDA challenge
    CRA consultants supported Endo International plc (Endo) in its successful challenge of products that infringed on its patents covering Opana® Extended Release...
    View engagement